Arthritis Care & Research recently published a paper from first author Astia Allenzara, MD, Assistant Professor of Medicine in the 黑料网 Division of Rheumatology, Allergy & Immunology, that aimed to examine patient-reported treatment goals among individuals with psoriatic arthritis (PsA).
Assessments completed by participants, including patient-reported outcome (PROs) instruments and two open-ended questions at time of enrollment or therapy initiation, helped to identify patients鈥� top improvement priority and treatment impact goals. The results from these assessments revealed that decreasing pain and improving skin were the most common improvement priorities among participants. The impact goals reported were more diverse, including but not limited to responses such as decreasing pain, general improvement in life, and the ability to be more active.
The heterogeneity of patient priorities in this study highlights the importance of understanding patient treatment goals to guide personalized management.
This study was possible from the mentorship of Dr. Alexis Ogdie, Associate Professor of Medicine and Director of the Center for Clinical Epidemiology and Biostatistics at University of Pennsylvania.
Allenzara A, Bush K, Husni ME, Reddy SM, Scher JU, Craig E, Koplin J, Walsh JA, Ogdie A. Diverse Treatment Goals in Psoriatic Arthritis: Insights from participants in the PARC cohort. Arthritis Care Res (Hoboken). 2025 Mar 23.